
Web Release Date: December 7,
A Multifaceted Phosphate Tether: Application to the C1-C14 Subunit of Dolabelides A-D
Department of Chemistry, University of Kansas, 1251 Wescoe Hall Drive, Lawrence, Kansas 66045
Received October 25, 2007
| Abstract: |
![]() |
In 1995, isolation and structural characterization of two new
22-membered macrolides, dolabelides A (1) and B,1 from
the sea hare Dolabella auricularia were reported. Isolation
of dolabelides C and D,2 24-membered macrolides, was
achieved from the same source. Cytotoxicity studies of
dolabelides A-D revealed promising results against cervical
cancer HeLa-S3 cells with IC50 values of 6.3, 1.3, 1.9, and
1.5
g/mL, respectively. Synthetic studies toward various
subunits of dolabelide have recently been reported.3 These
efforts include synthesis of protected intermediates of the
C1-C14 subunit, with Leighton and co-workers reporting
the properly acetylated C1-C14 fragment and completing
the only total synthesis of dolabelide D in 2006.4 Key features
common among the dolabelide family are 11 stereogenic
centers, eight of which bear oxygen, and two E-configured
The cornerstone for the title work hinged on recent studies,
countering historical views, which have revealed a functionally active phosphate triester tether5 within the P-chiral
bicyclic phosphate 5 (Scheme 1).6 These studies also revealed
selective cleavage pathways operative through displacement
reactions at carbon (SN2, SN2') and phosphorus, ultimately
| Scheme 1. Retrosynthetic Analysis of Dolabelide |
Retrosynthetic analysis shows that assembly of the C1-C14 (2) portion can be achieved via a Grignard addition into the C11 aldehyde, which is accessed by regioselective hydride opening of the advanced phosphate intermediate 4. Regioselective cross metathesis (CM) between bicyclic phosphate (R,R)-5 and terminal olefin 6 generates the C5-C6 bond and installs five of the six stereocenters found within the C1-C14 subunit of dolabelide. Bicyclic phosphate tether (R,R)-5 is readily constructed from the proper enantiomeric, C2-symmetric 1,3-anti-diol, (R,R)-7 via a P-tether-mediated diastereotopic differentiation using RCM. The C15-C30 portion of dolabelide can also be accessed using this phosphate methodology and the enantiomer of the C2-symmetric 1,3-anti-diol (S,S)-7.
Synthesis of CM partner 11 was achieved through initial reduction of TBS-protected Roche ester 8, followed by subsequent Swern oxidation of the alcohol, providing the necessary aldehyde 9 (Scheme 2).7 Reaction of the formed aldehyde with the Z-crotyl (-)-Ipc-borane generated enantiopure homoallylic alcohol 10 in 80% yield.8 PMB-protection of alcohol 10 was achieved using p-methoxybenzyl-bromide and sodium hydride to afford 11 in 95% yield.9
| Scheme 2. Synthesis of CM Partner 2.3 | |
| Scheme 3. CM Studies with Bicyclic Phosphate 5 |
A key component of the proposed synthesis of dolabelide
was the selective CM between bicyclic phosphate (R,R)-5,5a
and the synthesized homoallylic alcohol 11. Previous studies
have shown CM of bicyclic phosphate (R,R)-510 in which
the exocyclic olefin was shown to possess Type III olefin
behavior, implying that no detrimental homodimerization
pathways are operative.10,11
C),10 but incomplete consumption of the
starting phosphate was observed after 6 h (entry 4). Optimizing the reaction conditions with various solvents revealed
that use of toluene (90
C), with the same catalyst loading,
gave essentially the same results (entry 5). However, an
improved yield of 60% was obtained (entry 6) when 12 mol
% catalyst was added to the CM reaction. Switching to DCE
(90
C) and adding only 6 mol % Hoveyda-Grubbs catalyst
gave the optimized results for 11, providing 72% yield of
CM product 14 after 2 h. When removing the silyl protecting
group altogether, 13 furnished results similar to those with
11. It should be noted that in all cases excess 11, 12, 13,
Type II CM partners, could be recovered in near quantitative
yield and recycled in future CM events. This differential
reactivity pattern toward CM demonstrates that both proximal
and distal steric interactions play vital roles in the success
of selective CM reactions.13
With optimal CM conditions, 11 was chosen over 13,
owing to the facile removal of the silyl protecting group in
the late stages of the synthesis. The CM between (R,R)-5
and 11 provided phosphate 14 in 72% yield on multigram
scale (Scheme 4). Regioselective hydrogenation of exocyclic
C5-C6 olefin in the presence of the C10-C11 internal olefin
was paramount to allow for subsequent regioselective opening of the bicyclic system.
C) gave drastically
lower yields, likely due to bicyclic phosphate instability under
basic medium.
| Scheme 4. Selective Phosphate Cleavage in the Synthesis of Phosphate 17 |
C in DCE
selectively opened phosphate 15 to provide the desired
terminal olefin. Methylation of phosphate acid intermediate
showed that a highly regioselective process was operative
(37:1 ratio of regioisomers as evident by 31P NMR analysis).
Purification provided phosphate 17 in 87% yield. The
remarkable regioselectivity reveals another feature of the
phosphate tether, whereby orthogonal orbital alignment5
within 15 allows for selective Pd(0)-catalyzed allylic phosphate ionization at C12 over C9.
| Scheme 5. Synthesis of the C1-C15 Subunit of Dolabelide |
Installation of the C11-C14 fragment began with cleavage
of the phosphate 17 using LiAlH4, which generated a diol
that was subsequently protected as the acetonide (PPTS, 2,2-methoxypropane, DCM) to yield 18 in 96% yield (Scheme
5). Ozonolysis (O3, pyridine, DCM:MeOH 1:1, Me2S) of the
terminal olefin produced the intended aldehyde, which was
subjected to the Grignard generated from 1-iodo-3-methyl-3-butene16 affording 19 in a 95% yield. Dess-Martin
periodinane (DMP, NaHCO3, DCM) oxidation of the free
alcohol in 19 generated the requisite ketone in 90% yield.
Attempts to selectively reduce the acetonide protected ketone,
using an assortment of reducing agents, resulted in no
diastereoselectivity at C11.17 This problem seemed likely to
be circumvented by deprotection of the acetonide and
subsequent syn reduction utilizing the C9 free alcohol.
Removal of the acetonide was achieved by the addition of
CeCl3·7H2O and water,18 which efficiently cleaved the
acetonide protecting group without loss of the primary TBS
group and provided diol 20 in 86% yield. Final chelation-controlled reduction of ketone 20 using Et2BOMe and NaBH4
afforded triol 21 in 60% (95% based on recovered starting
material) with excellent diastereoselectivity (ds
20:1).
In conclusion, successful completion of the synthesis of the C1-C14 subunit of dolabelides A-D using phosphate tether methodology has been achieved. Overall, the phosphate tether serves a multifaceted role by (i) mediating the initial desymmetrization event leading to (R,R)-5, (ii) a selective Type III CM to couple two major complex fragments in the C1-C14 subunit of dolabelides, (iii) differentiating the two olefins within the bicyclic system 14, allowing for a selective hydrogenation, and finally (iv) serving as an excellent leaving group in a regioselective Pd(0)-mediated formate reduction. The route outlined above makes use of orthogonal protecting- and leaving group properties innate to phosphate esters. This work provides evidence that counters historical and traditional applications associated with the utilization of phosphates in synthesis. Efforts to complete the total synthesis are ongoing in our laboratories and will be reported in due course.
This investigation was supported by funds provided by NSF CHE-0503875, NIH RO1 GM077309, and the NIH Dynamic Aspects in Chemical Biology Training Grant (J.D.W.). We also thank Materia for supplying metathesis catalyst as well as Danielle Coverdell (University of Kansas) and John Nguyen (University of Kansas) for their synthetic contributions.
Experimental details and spectroscopic data of new compounds. This material is available free of charge via the Internet at http://pubs.acs.org.
* In papers with more than one author, the asterisk indicates the name of the author to whom inquiries about the paper should be addressed.
1. Ojika, M.; Nagoya, T.; Yamada, K. Tetrahedron Lett. 1995, 36,
7491-7494.![]()
2. Suenaga, K.; Nagoya, T.; Shibata, T.; Kigoshi, H.;Yamada, K. J.
Nat. Prod. 1997, 60, 155-157.![]()
3. (a) Grimaud, L.; Rotulo, D.; Ros-Perez, R.; Guitry-Azam, L.; Prunet,
J. Tetrahedron Lett. 2002, 43, 7477-7479.
(b) Grimaud, L.; de Mesmay,
R.; Prunet, J. Org. Lett. 2002, 4, 419-421.
(c) Desroy, N.; Le Roux, R.;
Phansavath, P.; Chiummiento, L.; Bonini, C.; Genet, J.-P. Tetrahedron Lett.
2003, 44, 1763-1766.
(d) Schmidt, D. R.; Park, P. K.; Leighton, J. L. Org.
Lett. 2003, 5, 3535-3537.
(e) Le Roux, R.; Desroy, N.; Phansavath, P.;
Genêt, J.-P. Synlett 2005, 429-432.
(f) Keck, G. E.; McLaws, M. D.
Tetrahedron Lett. 2005, 46, 4911-4914.
(g) Vincent A.; Prunet, J. Synlett
2006, 2269-2271.
4. Park, P. K.; O'Malley, S. J.; Schmidt, D. R.; Leighton, J. L. J. Am.
Chem. Soc. 2006, 128, 2796-2797.![]()
5. For examples of P(III)/P(V)-based tethers in synthesis, see: (a)
Rubinstenn, G.; Esnault, J.; Mallet, J.-M.; Sinay, P. Tetrahedron: Asymmetry
1997, 8, 1327-1336.
(b) Sprott, K. T.; McReynolds, M. D.; Hanson, P. R.
Org. Lett. 2001, 3, 3939-3942.![]()
6. For use of phosphate tethers in synthesis, see: (a) Whitehead, A.;
McReynolds, M. D.; Moore, J. D.; Hanson, P. R. Org. Lett. 2005, 7, 3375-3378.
(b) Whitehead, A.; McParland, J. P.; Hanson, P. R. Org. Lett. 2006,
8, 5025-5028.![]()
7. Burke, S. D.; Cobb, J. E.; Takeuchi, K. J. Org. Chem. 1990, 55,
2138-2151.![]()
8. (a) Hung, D. T.; Nerenberg, J. B.; Schreiber, S. L. J. Am. Chem.
Soc. 1996, 118, 11054-11080.
(b) Ramachandran, P. V.; Srivastava, A.;
Hazra, D. Org. Lett. 2007, 9, 157-160.![]()
9. Mínguez, J. M.; Kim, S.-Y.; Giuliano, K. A.; Balachandran, R.;
Madiraju, C.; Day, B. W.; Curran, D. P. Bioorg. Med. Chem. 2003, 11,
3335-3357.![]()
10. Waetzig, J. D.; Hanson, P. R. Org. Lett. 2006, 8, 1673-1676.![]()
11. Chatterjee, A. K.; Choi, T.-L.; Sanders, D. P.; Grubbs, R. H. J.
Am. Chem. Soc. 2003, 125, 11360-11370.![]()
12. (a) Chemler, S. R.; Roush, W. R. J. Org. Chem. 2003, 68, 1319-1333.
(b) Sneddon, H. F.; Gaunt, M. J.; Ley, S. V. Org. Lett. 2003, 5,
1147-1150.![]()
13. Hoye, T. R.; Jeffrey, C. S.; Tennakoon, M. A.; Wang, J.; Zhao, H.
J. Am. Chem. Soc. 2004, 126, 10210-10211.![]()
14. Myers, A. G.; Zheng, B.; Movassaghi, M. J. Org. Chem. 1997, 62,
7507.![]()
15. For a related study on using Pd-formate reductions to form terminal
olefins see: (a) Hughes, G.; Lautens, M.; Wen, C. Org. Lett. 2000, 2, 107-110.
(b) Chau, A.; Paquin, J.-F.; Lautens, M. J. Org. Chem. 2006, 71, 1924-1933.
16. Helmboldt, H.; Koehler, D.; Hiersemann, M. Org. Lett. 2006, 8,
1573-1576.![]()
17. See Supporting Information for further details.
18. Umezawa, T.; Hayashi, T.; Sakai, H.; Teramoto, H.; Yoshikawa,
T.; Izumida, M.; Tamatani, Y.; Hirose, T.; Ohfune, Y.; Shinada, T. Org.
Lett. 2006, 8, 4971-4974.![]()